First drug developed using machine learning enters clinical trials

Before a new medicine enters human trials, there is typically three to five years of work behind the scenes, researching causes for diseases and compounds that may help treat them. But working with British AI startup Exscientia, a Japanese drug development company called Sumitomo Dainippon Pharma Co. is about to…

Article Source